Active Pharmaceutical Ingredient

Rifaximin — CAS 116649-85-5

Also known as: Normix; Rifacol; Xifaxan; L/105

GMP Certified IP / BP / EP / USP Antibiotic / Rifamycin Derivative Aurangabad, India
Rifaximin API Supplier Manufacturer Aurangabad Maharashtra India — Mediocon Inc
Rifaximin IP / BP / EP / USP  |  GMP Certified  |  Mediocon Inc, Maharashtra, India
CAS No: 116649-85-5

Product Overview

Rifaximin is a high-purity Active Pharmaceutical Ingredient (API) classified as a non-absorbable oral antibiotic and Rifamycin derivative. Mediocon Inc manufactures GMP-compliant Rifaximin at its state-of-the-art facility in Aurangabad, Maharashtra, India.

Therapeutic Applications
  • Traveler's diarrhea caused by E. coli
  • Hepatic encephalopathy prevention and treatment
  • Irritable bowel syndrome with diarrhea (IBS-D)
  • Small intestinal bacterial overgrowth (SIBO)

Technical Specifications

ParameterSpecification
CAS Number116649-85-5
Molecular FormulaC₄₃H₅₁N₃O₁₁
Molecular Weight785.88 g/mol
GradeIP / BP / EP / USP
CategoryAntibiotic / Rifamycin Derivative
AssayNLT 98.0%
Loss on DryingNMT 0.5%
Heavy MetalsNMT 20 ppm
Residue on IgnitionNMT 0.1%
Microbial LimitsComplies with pharmacopoeia
IdentificationIR, HPLC Compliant
Batch NoRIF/24032026
Mfg DateMAR 2026
Exp DateFEB 2031
Packing25 kg HDPE drums / as per requirement

Quality & Compliance

  • GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
  • Full pharmacopoeial compliance: IP / BP / EP / USP standards
  • Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
  • Stringent in-process quality control at every manufacturing stage
  • HPLC purity testing and spectroscopic identification (IR, NMR)
  • Cold-chain and controlled-environment storage facilities available
  • Exported to 40+ countries with full regulatory support
💬
Mediocon AI
Hello 👋 How can I help you today?